Protocol Summaries: lavoltidine
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| LAV104616 | Phase 2 | See Detailed Description | Completed |
| LAV110285 | Phase 1 | An Open-Label study of the Development of Pharmacodynamic Tolerance to 7-days Administration of Lavoltidine 40mg | Completed |